As Americans cross their fingers, hoping the pandemic stays behind them, scientists across the country remain focused on the novel coronavirus, intent on combating its next move.
Mar 28, 2022
0
68
The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.
Mar 24, 2022
0
5
A new omicron subvariant of the virus that causes COVID-19, BA.2, is quickly becoming the predominant source of infections amid rising cases around the world. Immunologists Prakash Nagarkatti and Mitzi Nagarkatti of the University ...
Mar 23, 2022
0
3
When our immune system comes into contact with the SARS-CoV-2 coronavirus, it fights back and produces antibodies. A similar immune response is triggered by coronavirus vaccines. However, there is still little data available ...
Mar 18, 2022
0
7
COVID vaccines have been available to adults in the United States for more than a year, but there are still a lot of questions. Which vaccines have received full approval? When will we see vaccines approved for children under ...
Mar 17, 2022
0
2
As the effort to combat the SARS-CoV-2 virus began, among the most pressing questions were how to gauge its infectivity and get a better picture of those dynamics from the inside out. Answering them initially would bring ...
Mar 15, 2022
0
87
There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection. A new study from Karolinska Institutet in Sweden, and the Helmholtz Center Munich (HMGU) and the Technical ...
Mar 14, 2022
0
230
A recently identified hybrid of the Omicron and Delta coronavirus variants is unlikely to become a serious threat, scientists say.
Mar 14, 2022
0
24
While scientists have made unprecedented progress in preventing COVID-19 in the past two years, they have also moved closer to finding a vaccine to protect against the human immunodeficiency virus (HIV), which has been infecting ...
Mar 11, 2022
0
5
Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...
Feb 25, 2022
2
292
